Health economic evaluation of paricalcitol(®) versus cinacalcet + calcitriol (oral) in Italy. [corrected

Clinical Drug Investigation
M J C NuijtenThomas S Marshall

Abstract

Chronic kidney disease (CKD) is a highly morbid disorder. The most severe form of CKD is end-stage renal disease (ESRD), in which the patient requires some form of renal replacement therapy to survive. The increasing incidence, prevalence, and costs of ESRD are major national healthcare concerns. The objective of this study was to determine the cost effectiveness of two innovative therapies, paricalcitol versus cinacalcet + calcitriol (oral) in patients with CKD stage 5 (CKD 5) in the healthcare setting in Italy in 2013. A Markov process model was developed employing data sources from the published literature, paricalcitol clinical trials, official Italian price/tariff lists, and national population statistics. The analysis is based on a comparison of treatment with paricalcitol versus cinacalcet + calcitriol (oral) in CKD 5. The perspective of the study was that of the payer [Italian National Health Service (INHS)]. The primary efficacy outcomes in the paricalcitol and cinacalcet + calcitriol (oral) clinical trials (reduction of secondary hyperparathyroidism, complications, and mortality) were extrapolated to effectiveness outcomes: number of life-years gained (LYG) and number of quality-adjusted life-years (QALYs). Clinical a...Continue Reading

References

Feb 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D RubingerM M Popovtzer
Nov 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E SlatopolskyH DeLuca
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
May 1, 1997·Health Economics·M J BuxtonM Vray
Nov 25, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S Bro, K Olgaard
May 6, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C Díaz-CorteJ B Cannata Andía
Dec 18, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S HuraibA Iqbal
Feb 6, 1998·PharmacoEconomics·M J Nuijten
May 27, 1999·PharmacoEconomics·M NuijtenJ van den Berg
Sep 12, 2000·The American Journal of the Medical Sciences·M Yudd, F Llach
Nov 30, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M Coco, H Rush
Nov 2, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F Llach, F Velasquez Forero
Nov 2, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F Llach, M Yudd
Dec 3, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Daniel W CoyneEduardo Slatopolsky
Mar 13, 2003·Kidney International·Stuart M SpragueDaniel Batlle
Aug 2, 2003·The New England Journal of Medicine·Ming TengRavi Thadhani
Sep 10, 2003·PharmacoEconomics·Mark J C Nuijten, Frans Rutten
Oct 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T-Christian H MixAllan J Collins
Mar 9, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Deborah G DobrezStuart M Sprague
Jul 31, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Walter H Hörl
Feb 19, 2005·Advances in Chronic Kidney Disease·S L WhiteS J Chadban
Mar 10, 2005·The Medical Clinics of North America·Kambiz Zandi-Nejad, Barry M Brenner
May 13, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Roberto MinutoloBruno Cianciaruso
Dec 29, 2010·Journal of Nephrology·Sandro MazzaferroUNKNOWN FARO Study Group
Oct 10, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rafael KramannVincent M Brandenburg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.